The Brainy Stuff - Publications with RoosterBio Mesenchymal Stem Cells - RoosterBio Inc

The Brainy Stuff

MSCs are kind of our thing; we can’t get enough of them


Presentations, Posters and Other Brainy Stuff

Publications Using RoosterBio hMSCs and MEDIA SYSTEMS

2017

Biodegradable poly-ε-caprolactone microcarriers for efficient production of human mesenchymal stromal cells and secreted cytokines in batch and fed-batch bioreactors. Cytotherapy; 2017.

Substrate Stress-Relaxation Regulates Scaffold Remodeling and Bone Formation In Vivo. Adv Healthcare Mat; 2017.

Collagen hydrogel scaffold promotes mesenchymal stem cell and endothelial cell coculture for bone tissue engineering. J Biomed Mater Res A; 2017.

In Vivo Chondrogenesis in 3D Bioprinted Human Cell-laden Hydrogel Constructs. Plast Reconstr Surg Glob Open; 2017.

Bioprocess integration for human mesenchymal stem cells: From up to downstream processing scale-up to cell proteome characterization. J Biotechnol; 2017.

Deformability of Human Mesenchymal Stem Cells Is Dependent on Vimentin Intermediate Filaments. Ann Biomed Eng; 2017.

2016

Hypoxic Expansion of Human Mesenchymal Stem Cells Enhances 3D Maturation of Tissue Engineered Intervertebral Discs. Tissue Eng Part A; 2016.

Growth Factor Dose Tuning for Bone Progenitor Cell Proliferation and Differentiation on Resorbable Poly(propylene fumarate) Scaffolds. Tissue Eng Part C; 2016.

Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs. Stem Cell Transl Med; 2016.

In vitro cytokine licensing induces persistent permissive chromatin at the Indoleamine 2,3-dioxygenase promoter.  Cytotherapy; 2016.

Three-Dimensional Mechanical Loading Modulates the Osteogenic Response of Mesenchymal Stem Cells to Tumor-Derived Soluble Signals.  Tissue Engineering Part A; 2016.

Growth Factor Dose Tuning for Bone Progenitor Cell Proliferation and Differentiation on Resorbable Poly(propylene fumarate) Scaffolds. Tissue Engineering Part C; 2016.

3D Printed Vascular Networks Enhance Viability in High-Volume Perfusion Bioreactor. Annals of Biomedical Engineering; 2016.

Further observations on the behavioral and neural effects of bone marrow stromal cells in rodent pain models.  Mol Pain; 2016.

Identification of Predictive Gene Markers for Multipotent Stromal Cell Proliferation.  Stem Cells Dev; 2016.

Open-Source Selective Laser Sintering (OpenSLS) of Nylon and Biocompatible Polycaprolactone. PLoS One; 2016.

A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer. Biomaterials; 2016.

Development and characterization of a naturally derived lung extracellular matrix hydrogel. J Biomed Mater Res; 2016.

Three-dimensional bioprinting of thick vascularized tissues. PNAS Early Edition; 2016.

Collagen Type II enhances chondrogenic differentiation in agarose-based modular microtissues.  Cytotherapy; 2016.

Dynamic Bioreactor Culture of High Volume Engineered Bone Tissue. Tissue Engineering Part A. 2016.

Ultrahigh-throughput Generation and Characterization of Cellular Aggregates in Laser-ablated Microwells of Poly(dimethylsiloxane). RSC Adv; 2016.

Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures. The Prostate; 2016.

Synthesis and Biological Evaluation of Well-Defined Poly(propylene fumarate) Oligomers and Their Use in 3D Printed Scaffolds. Biomacromolecules; 2016.

2015

Serum-free media formulations are cell line-specific and require optimization for microcarrier culture.  Cytotherapy; 2015.

Self-Healing and Thermoresponsive Dual-Cross-Linked Alginate Hydrogels Based on Supramolecular Inclusion Complexes. Biomacromolecules; 2015.

 

Customer/Collaborator Work with RoosterBio hMSCs

From the lab of Jordan Miller at Rice University: Open-source Selective Laser Sintering (OpenSLS) of nylon and biocompatible polycaprolactone. To be presented at World Biomaterials Congress; Montreal, Canada; May, 2016.

From the lab of Jordan Miller at Rice University: Engineered tissues with perfusable vascular networks created by sacrificial templating of laser sintered carbohydrates. To be presented at World Biomaterials Congress; Montreal, Canada; May, 2016.

From the lab of Jordan Miller at Rice University: Tubulogenesis of iPS Endothelial Cells Stabilized by Human Mesenchymal Stem Cells in Fibrin Gels. To be presented at World Biomaterials Congress; Montreal, Canada; May, 2016.

From the lab of Larry Bonassar at Cornell: Differential MHC Class Receptor Expression in In Vitro Human Mesenchymal Stem Cells is Mediated by Scaffold Material.  Presented at ORS; Orlando, FL; March, 2016.

From the lab of Larry Bonassar at Cornell: Effect of Hypoxia on 2D and 3D Culture of Human MSCs Used for Tissue Engineering of Whole Intervertebral Discs. Presented at ORS; Orlando, FL; March, 2016.

From the lab of Larry Bonassar at Cornell: Co-Implantation of Auricular Chondrocytes and Mesenchymal Stem Cells for Auricular Cartilage Generation. Presented at TERMIS World Congress; Boston, MA; Dec, 2015.

From the lab of Eric Brey at Illinois Institute of Technology: Evaluation of MSC Source on Angiogenesis in 3D Co-Culture. Presented at TERMIS World Congress; Boston, MA; Dec, 2015.

From the lab of Larry Bonassar at Cornell: The Influence of TGF-β3 on the Maturation of Tissue Engineered IVDs Containing Highly Contractile Human MSCs. Presented at ORS; Las Vegas, NV; March, 2015.

From the lab of Lisa Larkin at U Michigan: Characterization of a Human MSC Population Required for Scaffold-less Construct Fabrication. Presented at ORS; Las Vegas, NV; March, 2015.

RoosterBio-BioBots collaboration: Welcome to the Golden Age of BioPrinting, Tissue Engineering and BioFabrication. Frederick, MD; Dec, 2014.

From PBS Biotech: Screening Study of Key Process Conditions for Anchorage-Dependent Stem Cell Cultivation in Scale-Down Model of Vertical-Wheel Bioreactors. Presented at Scale-Up and Manufacturing of Cell Therapies IV; San Diego, CA; Jan, 2015.

 

RoosterBio Presentations 

Economics and Quality Attributes of hMSC Production in Xeno-free Bioprocessing Media. Scale-up and Manufacturing of Cell-based Therapies V; San Diego, CA; January 15-19, 2017.

Cost and Quality Attributes of hMSC Production in Xeno-free Bioprocessing Media. BPI Cell & Gene Therapy Conference; Boston, MA; October 5-7, 2016.


Scalable Expansion OF hBM-MSC in a Fed-Batch Microcarrier Suspension Bioreactor. ISSCR; San Francisco, CA; June 22-25, 2016.

Scalable bioreactor-based production of human Mesenchymal Stem Cell (hMSC) 3D aggregates using microcarriers with thermo-reversible surfacesISSCR; San Francisco, CA; June 22-25, 2016.

Cryopreserved hMSCs maintain comparable in vitro functional activity compared to fresh hMSCs. Presented at ISCT; Las Vegas, NV; May 27-30, 2015.

Rapid and Economic Generation of consistent hMSC Spheroids for Macroscopic Tissue Biofabrication and Therapeutic Applications. Presented at ISCT; Las Vegas, NV; May, 2015.

A Standardized and Well-Characterized MSC Source for Rapid Biofabrication & Translational Research. Presented at TERMIS AM; Washington, DC; Dec, 2014.

Consistent Enhancement of Mesenchymal Stem Cells (MSC) Function and Properties by IFNγ and TNFα Treatment In Vitro. Presented at TERMIS AM; Washington, DC; Dec, 2014.

A Standardized and Well-Characterized MSC Source for Translational Researchers. Presented at the McGowan Institute Retreat; Nemacolin Woodlands, PA; March, 2014.

 

Best Practices in hMSC Culture

Best Practices in hMSC Culture - PDL vs. Passage Number

To request a PDL and DT Calculator Excel Spreadsheet, please email us at info@roosterbio.com.

 

Relevant Publications

An in-depth look at MSCs

What does MSC stand for, when were they discovered, what is RoosterBio’s solution to the MSC Research bottleneck?

Learn More

Frequently Asked Questions

RoosterBio MSCs and Media System FAQs
Smart questions with our in-depth answers

FAQs